Skip to main content
. 2010 Sep 15;92(5):1060–1070. doi: 10.3945/ajcn.2010.29188

TABLE 1.

Baseline demographic, clinical, and laboratory values in 742 maintenance hemodialysis patients at the start of the 5-y cohort study1

All (n = 742) Men (n = 391) Women (n = 351) P value2
Age (y) 54 ± 153 53 ± 15 55 ± 15 0.13
Race (% African American) 31 28 34 0.06
Ethnicity (% Hispanic) 52 54 49 0.17
Primary insurance (% receiving Medicare) 52 51 52 0.74
Diabetes mellitus (%) 53 51 56 0.19
Marital status (% married) 48 60 37 <0.01
Charlson comorbidity score 1.9 ± 1.6 1.9 ± 1.6 1.8 ± 1.6 0.95
BMI (kg/m2) 26.5 ± 5.8 25.3 ± 5.0 27.3 ± 6.4 <0.01
NIR interactance–measured body fat (%) 26.4 ± 10.8 19.5 ± 18.1 34.1 ± 7.7 <0.01
NIR interactance–measured fat mass (kg) 19.8 ± 11.5 15.3 ± 19.6 24.8 ± 11.4 <0.01
NIR interactance–measured LBM (kg) 52.0 ± 10.9 58.6 ± 8.7 44.6 ± 8.0 <0.01
Triceps-skinfold thickness (mm) 17.3 ± 9.5 12.9 ± 7.3 22.2 ± 9.9 <0.01
Biceps-skinfold thickness (mm) 9.7 ± 7.8 7.3 ± 6.5 12.4 ± 8.2 <0.01
MAMC (cm) 25.7 ± 4.3 26.3 ± 3.8 25.1 ± 4.8 <0.01
Dialysis vintage (mo) 28 ± 26 27 ± 25 29 ± 26 0.95
Dialysis dose, single pool (Kt/V) 1.62 ± 0.30 1.53 ± 0.26 1.71 ± 0.31 <0.01
nPNA (kg/d) 1.07 ± 0.22 1.09 ± 0.24 1.06 ± 0.22 0.10
Serum albumin (mg/dL) 3.90 ± 0.36 3.97 ± 0.37 3.82 ± 0.32 <0.01
Prealbumin (mg/dL) 28.6 ± 9.5 29.6 ± 9.9 27.5 ± 9.0 <0.01
Creatinine (mg/dL) 10.2 ± 3.2 10.9 ± 3.3 9.5 ± 2.9 <0.01
C-reactive protein (mg/L) 5.6 ± 7.0 5.8 ± 7.7 5.4 ± 6.0 <0.01
IL-6 (pg/mL) 11.7 ± 15.7 10.8 ± 12.2 11.8 ± 15.7 <0.01
TNF-α (pg/mL) 8.6 ± 11.4 8.7 ± 12.4 8.5 ± 10.0 <0.01
1

NIR, near-infrared; IL-6, interleukin-6; TNF-α, tumor necrosis factor-α; LBM, lean body mass; MAMC, midarm muscle circumference; nPNA, total nitrogen appearance normalized to body weight; Kt/V, urea clearance over time.

2

Independent-samples t test for men compared with women.

3

Mean ± SD (all such values).